Gideon Aweh
Overview
Explore the profile of Gideon Aweh including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
361
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Manley H, Lacson Jr E, Aweh G, Li N, Weiner D, Miskulin D, et al.
Am J Kidney Dis
. 2022 Mar;
80(3):309-318.
PMID: 35288216
Rationale & Objective: High-dose influenza vaccine provides better protection against influenza infection in older adults than standard-dose vaccine. We compared vaccine seroresponse among hemodialysis patients over a period of 4...
2.
Manley H, Aweh G, Frament J, Ladik V, Lacson E
Nephrol Dial Transplant
. 2022 Feb;
38(2):447-454.
PMID: 35150277
Background: Vaccination against hepatitis B virus (HBV) is recommended for dialysis patients. Two reports comparing seroprotection (SP) rates following HepB and HepB-CpG in vaccine-naïve patients with chronic kidney disease enrolled...
3.
Lacson Jr E, Argyropoulos C, Manley H, Aweh G, Chin A, Salman L, et al.
J Am Soc Nephrol
. 2021 Aug;
32(11):2735-2742.
PMID: 34348908
Background: Patients receiving maintenance dialysis represent a high-risk, immune-compromised population with 15%-25% COVID-19 mortality rate who were unrepresented in clinical trials of mRNA vaccines. Methods: All patients receiving maintenance dialysis...
4.
Hsu C, Weiner D, Aweh G, Salenger P, Johnson D, Lacson Jr E
J Am Soc Nephrol
. 2021 Jun;
32(7):1569-1573.
PMID: 34108232
No abstract available.
5.
Lacson E, Argyropoulos C, Manley H, Aweh G, Chin A, Salman L, et al.
medRxiv
. 2021 Apr;
PMID: 33880482
Background: Patients receiving maintenance dialysis represent a high risk, immune-compromised population with 15-25% COVID mortality rate who were unrepresented in clinical trials evaluated for mRNA vaccines' emergency use authorization. Method:...
6.
Hsu C, Weiner D, Aweh G, Miskulin D, Manley H, Stewart C, et al.
Am J Kidney Dis
. 2021 Jan;
77(5):748-756.e1.
PMID: 33465417
Rationale & Objective: During the coronavirus disease 2019 (COVID-19) pandemic, patients receiving maintenance dialysis are a highly vulnerable population due to their comorbidities and circumstances that limit physical distancing during...
7.
Manley H, Aweh G, Weiner D, Jiang H, Miskulin D, Johnson D, et al.
Am J Kidney Dis
. 2020 Mar;
76(1):13-21.
PMID: 32173107
Rationale & Objectives: Dialysis patients frequently experience medication-related problems. We studied the association of a multidisciplinary medication therapy management (MTM) with 30-day readmission rates. Study Design: Retrospective cohort study. Setting...
8.
Savageau J, Keller D, Willis G, Muhr K, Aweh G, Simons J, et al.
J Pediatr
. 2016 Aug;
178:261-267.
PMID: 27546203
Objective: To assess the impact of a Massachusetts Medicaid policy change (the Children's Behavioral Health Initiative; CBHI, which required and reimbursed behavioral health [BH] screening with standardized tools at well...
9.
Clark R, Baxter J, Aweh G, OConnell E, Fisher W, Barton B
J Subst Abuse Treat
. 2015 May;
57:75-80.
PMID: 25997674
Clinical trials show that opioid agonist therapy (OAT) with methadone or buprenorphine is more effective than behavioral treatments, but state policymakers remain ambivalent about covering OAT for long periods. We...
10.
Baxter J, Clark R, Samnaliev M, Aweh G, OConnell E
Subst Abus
. 2015 Feb;
36(2):174-82.
PMID: 25706332
Background: Buprenorphine is the most frequently prescribed medication for treating substance use disorders in the United States, but few studies have evaluated the structure of treatment delivered in real-world settings....